These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19958895)

  • 41. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ruan SY; Lin HH; Huang CT; Kuo PH; Wu HD; Yu CJ
    Crit Care; 2014 Apr; 18(2):R63. PubMed ID: 24708846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong.
    Chan HL; Tsang OT; Hui YT; Fung J; Lui GC; Lai CL; Wong GL; Chan KH; But DY; Lai MS; Lao WC; Chan CK; Lam YS; Seto WK; Li C; Yuen MF; Wong VW
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1230-1233. PubMed ID: 27869328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of corticosteroid therapy in the early phase of acute respiratory distress syndrome: a propensity-matched cohort study.
    Baek MS; Lee Y; Hong SB; Lim CM; Koh Y; Huh JW
    Korean J Intern Med; 2021 Jan; 36(1):145-153. PubMed ID: 32114751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis.
    Zhou Y; Fu X; Liu X; Huang C; Tian G; Ding C; Wu J; Lan L; Yang S
    Sci Rep; 2020 Feb; 10(1):3044. PubMed ID: 32080223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.
    Omrani AS; Saad MM; Baig K; Bahloul A; Abdul-Matin M; Alaidaroos AY; Almakhlafi GA; Albarrak MM; Memish ZA; Albarrak AM
    Lancet Infect Dis; 2014 Nov; 14(11):1090-1095. PubMed ID: 25278221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis.
    Arab-Bafrani Z; Jabbari A; Mostakhdem Hashemi M; Arabzadeh AM; Gilanipour A; Mousavi E
    J Antimicrob Chemother; 2019 Dec; 74(12):3432-3439. PubMed ID: 31369086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study.
    Shionoya Y; Taniguchi T; Kasai H; Sakuma N; Imai S; Shikano K; Takayanagi S; Yahaba M; Nakada TA; Igari H; Sakao S; Suzuki T
    PLoS One; 2021; 16(9):e0256977. PubMed ID: 34473766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients.
    Lee N; Leo YS; Cao B; Chan PK; Kyaw WM; Uyeki TM; Tam WW; Cheung CS; Yung IM; Li H; Gu L; Liu Y; Liu Z; Qu J; Hui DS
    Eur Respir J; 2015 Jun; 45(6):1642-52. PubMed ID: 25573405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.
    Moler FW; Steinhart CM; Ohmit SE; Stidham GL
    J Pediatr; 1996 Mar; 128(3):422-8. PubMed ID: 8774517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
    Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
    BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
    Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU
    Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy.
    Cotugno N; Manno EC; Stoppa F; Sinibaldi S; Saffirio C; D'Argenio P; Marano M; Di Nardo M; Palma P
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.
    Park SY; Baek S; Lee SO; Choi SH; Kim YS; Woo JH; Sung H; Kim MN; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Antimicrob Agents Chemother; 2013 Feb; 57(2):983-9. PubMed ID: 23229488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
    Tsui PT; Kwok ML; Yuen H; Lai ST
    Emerg Infect Dis; 2003 Sep; 9(9):1064-9. PubMed ID: 14519241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
    Hung IF; Lung KC; Tso EY; Liu R; Chung TW; Chu MY; Ng YY; Lo J; Chan J; Tam AR; Shum HP; Chan V; Wu AK; Sin KM; Leung WS; Law WL; Lung DC; Sin S; Yeung P; Yip CC; Zhang RR; Fung AY; Yan EY; Leung KH; Ip JD; Chu AW; Chan WM; Ng AC; Lee R; Fung K; Yeung A; Wu TC; Chan JW; Yan WW; Chan WM; Chan JF; Lie AK; Tsang OT; Cheng VC; Que TL; Lau CS; Chan KH; To KK; Yuen KY
    Lancet; 2020 May; 395(10238):1695-1704. PubMed ID: 32401715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report.
    Yoon BW; Lee SH
    J Med Case Rep; 2017 Dec; 11(1):353. PubMed ID: 29258592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.